News
Overall survival was analyzed in real-world patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223.
SNMMI annual meeting featured a prostate cancer session and a presentation by Dr. Sabina Dizdarevic discussing sequencing and combining beta and alpha targeted radionuclide treatments in the ...
LANSING, Mich. and DELFT, Netherlands, June 20, 2025 /PRNewswire/ -- IONETIX, a leading cyclotron technology innovator and full-service isotope manufacturer, and AlfaRim, a Dutch deeptech company ...
Marie Curie worked with radioactive material with her bare hands. More than 100 years later, Sophie Hardach travels to Paris ...
CASE-history data are presented on 12 women who have carried in their skeletons for many years toxicologically interesting burdens of the radioisotopes Ra226 (radium, or Ra) and Ra228 (mesothorium, ...
Radium Ra 223 Dichloride(Xofigo) generic is an alpha particle-emitting radioactive therapeutic agent indicated for treatment of patients with metastatic castration-resistant prostate cancer (mCRPC ...
Review the side-effects of Radium Ra 223 Dichloride as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.
Find patient medical information for Xofigo (radium Ra 223 dichloride) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...
Radioactive molecules containing octupole deformed nuclei, such as radium (Ra), promise to be exceptional quantum systems for use in studies of the fundamental particles and forces of nature.
Radioactive molecules containing octupole deformed nuclei, such as radium (Ra), promise to be exceptional quantum systems for use in studies of the fundamental particles and forces of nature.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results